G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020

NEXT STORY
TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
PREV STORY
Teleflex to Present at the Bank of America Merrill Lynch 2020 Health Care Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2015 Financial Results

BERKELEY HEIGHTS, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

author_avatar
NASDAQ Market News

Prolaris® Test Identifies Men with Prostate Cancer Who Can Safely Defer Treatment

author_avatar
NASDAQ Market News

Epizyme to Present New Preclinical Data on Tazemetostat and Epigenetic Target Identification Efforts at AACR Annual Meeting

CAMBRIDGE, Mass., March 29, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News